We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists (DELAY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01366053
Recruitment Status : Completed
First Posted : June 3, 2011
Last Update Posted : December 22, 2016
Ferring Pharmaceuticals
Information provided by (Responsible Party):
CMX Research

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2015
  Study Completion Date : July 2015